MTOR and neoplasm: Tumor samples from the patients were analyzed for molecular markers, finding that those expressing mTOR Ser-2448 phosphorylated were associated with a longer survival (mean survival was 17.8 months for temsirolimus-treated patients showing p-mTOR Ser-2448 vs. 13.1 months in negative cases for the marker) [276].